US Stock MarketDetailed Quotes

LENZ LENZ Therapeutics

Watchlist

15.475
-0.015-0.10%

Trading May 30 11:25 ET

395.15MMarket Cap-1252P/E (TTM)

LENZ Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-87.04%-23.94M

-1,375.92%-60.38M

-180.99%-20.97M

-12.8M

24.16%-4.09M

-7.46M

-5.39M

Net income from continuing operations

-31.40%-16.65M

-547.19%-69.97M

-151.27%-23.69M

---12.67M

-42.95%-10.81M

---9.43M

---7.56M

Operating gains losses

6,443.75%1.05M

-485.71%-123K

-5,280.00%-269K

--16K

-102.56%-21K

---5K

--819K

Depreciation and amortization

66.67%5K

87.50%15K

33.33%4K

--3K

300.00%8K

--3K

--2K

Change In working capital

-3,018.69%-9.01M

56.52%9.41M

87.30%2.98M

---289K

421.88%6.01M

--1.59M

--1.15M

-Change in prepaid assets

-221.60%-518K

136.03%761K

122.64%276K

--426K

-13,100.00%-2.11M

---1.22M

---16K

-Change in payables and accrued expense

-1,088.11%-8.5M

5.96%8.64M

-3.77%2.7M

---715K

596.84%8.15M

--2.81M

--1.17M

-Change in other current assets

----

134.48%10K

--0

----

-1,350.00%-29K

--0

---2K

Cash from discontinued investing activities

Operating cash flow

-87.04%-23.94M

-1,375.92%-60.38M

-180.99%-20.97M

---12.8M

24.16%-4.09M

---7.46M

---5.39M

Investing cash flow

Cash flow from continuing investing activities

300,100.00%18M

-79,956.76%-29.62M

505,866.67%15.17M

-6K

-311.11%-37K

-3K

-9K

Net PPE purchase and sale

--0

18.92%-30K

--0

---6K

-311.11%-37K

---3K

---9K

Net investment purchase and sale

--18M

---29.59M

--15.17M

--0

----

Cash from discontinued investing activities

Investing cash flow

300,100.00%18M

-79,956.76%-29.62M

505,866.67%15.17M

---6K

-311.11%-37K

---3K

---9K

Financing cash flow

Cash flow from continuing financing activities

105.90%171.27M

166.67%80.7M

-109.43%-1.91M

83.18M

32.93%30.26M

20.26M

22.77M

Net common stock issuance

--53.39M

----

--0

----

Net preferred stock issuance

--0

175.37%82.98M

--0

--82.98M

32.37%30.13M

--20.24M

--22.77M

Proceeds from stock option exercised by employees

111.82%430K

57.36%203K

--0

--203K

--129K

--15K

--0

Net other financing activities

--117.45M

---2.48M

---1.91M

----

Cash from discontinued financing activities

Financing cash flow

105.90%171.27M

166.67%80.7M

-109.43%-1.91M

--83.18M

32.93%30.26M

--20.26M

--22.77M

Net cash flow

Beginning cash position

-20.93%35.14M

142.75%44.44M

35.37%42.85M

--44.44M

1,837.25%18.31M

--31.65M

--945K

Current changes in cash

134.93%165.33M

-135.59%-9.3M

-160.27%-7.71M

--70.38M

50.52%26.13M

--12.79M

--17.36M

End cash Position

74.60%200.47M

-20.93%35.14M

--114.82M

142.75%44.44M

--44.44M

--18.31M

Free cash flow

-86.95%-23.94M

-1,363.42%-60.41M

-180.87%-20.97M

---12.8M

23.60%-4.13M

---7.47M

---5.4M

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-87.04%-23.94M	-1,375.92%-60.38M	-180.99%-20.97M	-12.8M	24.16%-4.09M	-7.46M	-5.39M
Net income from continuing operations	-31.40%-16.65M	-547.19%-69.97M	-151.27%-23.69M	---12.67M	-42.95%-10.81M	---9.43M	---7.56M
Operating gains losses	6,443.75%1.05M	-485.71%-123K	-5,280.00%-269K	--16K	-102.56%-21K	---5K	--819K
Depreciation and amortization	66.67%5K	87.50%15K	33.33%4K	--3K	300.00%8K	--3K	--2K
Change In working capital	-3,018.69%-9.01M	56.52%9.41M	87.30%2.98M	---289K	421.88%6.01M	--1.59M	--1.15M
-Change in prepaid assets	-221.60%-518K	136.03%761K	122.64%276K	--426K	-13,100.00%-2.11M	---1.22M	---16K
-Change in payables and accrued expense	-1,088.11%-8.5M	5.96%8.64M	-3.77%2.7M	---715K	596.84%8.15M	--2.81M	--1.17M
-Change in other current assets	----	134.48%10K	--0	----	-1,350.00%-29K	--0	---2K
Cash from discontinued investing activities
Operating cash flow	-87.04%-23.94M	-1,375.92%-60.38M	-180.99%-20.97M	---12.8M	24.16%-4.09M	---7.46M	---5.39M
Investing cash flow
Cash flow from continuing investing activities	300,100.00%18M	-79,956.76%-29.62M	505,866.67%15.17M	-6K	-311.11%-37K	-3K	-9K
Net PPE purchase and sale	--0	18.92%-30K	--0	---6K	-311.11%-37K	---3K	---9K
Net investment purchase and sale	--18M	---29.59M	--15.17M	--0	----	----	----
Cash from discontinued investing activities
Investing cash flow	300,100.00%18M	-79,956.76%-29.62M	505,866.67%15.17M	---6K	-311.11%-37K	---3K	---9K
Financing cash flow
Cash flow from continuing financing activities	105.90%171.27M	166.67%80.7M	-109.43%-1.91M	83.18M	32.93%30.26M	20.26M	22.77M
Net common stock issuance	--53.39M	----	----	--0	----	----	----
Net preferred stock issuance	--0	175.37%82.98M	--0	--82.98M	32.37%30.13M	--20.24M	--22.77M
Proceeds from stock option exercised by employees	111.82%430K	57.36%203K	--0	--203K	--129K	--15K	--0
Net other financing activities	--117.45M	---2.48M	---1.91M	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	105.90%171.27M	166.67%80.7M	-109.43%-1.91M	--83.18M	32.93%30.26M	--20.26M	--22.77M
Net cash flow
Beginning cash position	-20.93%35.14M	142.75%44.44M	35.37%42.85M	--44.44M	1,837.25%18.31M	--31.65M	--945K
Current changes in cash	134.93%165.33M	-135.59%-9.3M	-160.27%-7.71M	--70.38M	50.52%26.13M	--12.79M	--17.36M
End cash Position	74.60%200.47M	-20.93%35.14M	-20.93%35.14M	--114.82M	142.75%44.44M	--44.44M	--18.31M
Free cash flow	-86.95%-23.94M	-1,363.42%-60.41M	-180.87%-20.97M	---12.8M	23.60%-4.13M	---7.47M	---5.4M
Currency Unit	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall